(ANSA) - ROME, JUL 08 - The production value of the pharmaceutical industry in Italy in 2020 is over 34 billion euros, at the top of the European Union, with France and Germany. The growth in production is entirely linked to exports, which grew by 74% between 2015 and 2020, and to the increase in the average values of exported drugs (+ 50%). An export that in the last 5 years has recorded an increase of 14 billion, 2/3 of the total of the country. While the internal market is compressed and down in 2020. These are some of the data presented today at the Public Assembly of Farmindustria in Rome.
The pharmaceutical industry, explained in his report the president of Farmindustria, Massimo Scaccabarozzi, is also "the leader in female employment that reaches 43% of employees compared to 29% of the rest of the economy. And women who often hold positions of responsibility": in fact, 42% of executives and middle managers (and 52% among the under 40s), demonstrating the fact that, in the pharmaceutical sector, gender equality has been a reality for years. "
Pharmaceutical companies in Italy have a
unique
composition in Europe: 43% with Italian capital, 57% with international capital. And "they are all, large, small and medium-sized, strongly rooted in the territory", he specified. They are present in the North and Center with leading industrial centers in Europe, but also in the South.with many Italian and international companies ".
Pharmaceutical companies, he concluded, "also pay a great deal of attention to environmental sustainability": in 10 years, in fact, they have reduced energy consumption in Italy by 59% and climate-altering gas emissions by 32%. (HANDLE).